Seoul healthcare technology company developing the F5 Toothbrush, which uses electrical stimulation to prevent plaque.
Founded in 2019 and based in Seoul, South Korea, ProxiHealthcare develops the F5 Toothbrush, which uses electrical stimulation to prevent plaque formation. In August 2022 it raised KRW 8.2 billion in Series A funding from returning investor FuturePlay, with new investors Timewise Investment, Maple Investment Partners, Infobank, HB Investment and BSK Investment. The funding will support product development, production facility expansion and marketing.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in